Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
The Brighterside of News on MSN
12h
Weight-loss drug Semaglutide could significantly reduce the risk of heart attacks
A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...
Pharmabiz
23h
EMA committee recommends Novo Nordisk’s Wegovy label update to reflect reduced heart failure symptoms and improved physical function
Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Actress Crosby dies at 90
CA firefighter held for arson
Released after guilty plea
Ga. suspect's mom indicted
Sesame Place suit verdict
J&J unit files for bankruptcy
Feds subpoena Schaeffer
Biden hosts 'Quad' summit
TN abortion law blocked
To skip Al Smith dinner
Rejects CNN debate invite
Suns broadcaster dies
Beirut strike death toll
Bill to boost security OK'd
Hand count approved in GA
In-person voting begins
ISR strike on Gaza school
CA bill to protect kids online
CAH sues for trespassing
Sues pharmacy middlemen
Pandas leaving for China
Drug price challenge revived
House repeals emission rules
144K+ Mavericks recalled
FDA approves flu vaccine
WI high court to decide
Boeing defense chief exits
SC 1st execution in 13 years
Hiker injured in bear attack
Related topics
Novo Nordisk
Wegovy
European Medicines Agency
Feedback